Feasibility and efficacy of thrombolysis in acute ischemic stroke: A study from National Institute of Neurological and Allied Sciences, Kathmandu, Nepal

BACKGROUND: Stroke is the major cause of morbidity and mortality worldwide. The number of stroke patients receiving recombinant tissue plasminogen activator (rt-PA), also known as Alteplase, in the developing world is extremely low. We aim to study the feasibility and efficacy of thrombolysis for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Thapa, Lekhjung, Shrestha, Shikher, Shrestha, Pratyush, Bhattarai, Suman, Gongal, D N, Devkota, U P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750341/
https://www.ncbi.nlm.nih.gov/pubmed/26933345
http://dx.doi.org/10.4103/0976-3147.172161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750341/
https://www.ncbi.nlm.nih.gov/pubmed/26933345
http://dx.doi.org/10.4103/0976-3147.172161

Ejemplares similares